Liu W - Search Results

1

Construction and Preclinical Evaluation of 211At Labeled Anti-mesothelin Antibodies as Potential Targeted Alpha Therapy Drugs.

Wang X, Ma W, Liu W, Ma H, Yang Y, Wang Y, Liu N, Yang G. Wang X, et al. Among authors: liu n, liu w. J Radiat Res. 2020 Sep 8;61(5):684-690. doi: 10.1093/jrr/rraa049. J Radiat Res. 2020. PMID: 32648573 Free PMC article.

2

A radiopharmaceutical [⁸⁹Zr]Zr-DFO-nimotuzumab for immunoPET with epidermal growth factor receptor expression in vivo.

Tang Y, Hu Y, Liu W, Chen L, Zhao Y, Ma H, Yang J, Yang Y, Liao J, Cai J, Chen Y, Liu N. Tang Y, et al. Among authors: liu n, liu w. Nucl Med Biol. 2019 Mar;70:23-31. doi: 10.1016/j.nucmedbio.2019.01.007. Epub 2019 Feb 8. Nucl Med Biol. 2019. PMID: 30826708

3

A Theoretical Model for Predicting and Optimizing In Vitro Screening of Potential Targeted Alpha-Particle Therapy Drugs.

Ma W, Wang X, Liu W, Ma H, Su Y, Yang Y, Liu N, Wang Y, Yang G. Ma W, et al. Among authors: liu n, liu w. Radiat Res. 2019 May;191(5):475-482. doi: 10.1667/RR15297.1. Epub 2019 Mar 4. Radiat Res. 2019. PMID: 30830838

4

Simple and efficient method for producing high radionuclidic purity ¹¹¹In using enriched ¹¹²Cd target.

Gao J, Liao Z, Liu W, Hu Y, Ma H, Xia L, Li F, Lan T, Yang Y, Yang J, Liao J, Liu N. Gao J, et al. Among authors: liu n, liu w. Appl Radiat Isot. 2021 Oct;176:109828. doi: 10.1016/j.apradiso.2021.109828. Epub 2021 Jun 13. Appl Radiat Isot. 2021. PMID: 34166947

5

Synthesis and Preliminary Evaluation of ¹³¹I-Labeled FAPI Tracers for Cancer Theranostics.

Ma H, Li F, Shen G, Cai H, Liu W, Lan T, Yang Y, Yang J, Liao J, Liu N. Ma H, et al. Among authors: liu n, liu w. Mol Pharm. 2021 Nov 1;18(11):4179-4187. doi: 10.1021/acs.molpharmaceut.1c00566. Epub 2021 Sep 30. Mol Pharm. 2021. PMID: 34591481

6

In vitro and in vivo evaluation of ²¹¹At-labeled fibroblast activation protein inhibitor for glioma treatment.

Ma H, Li F, Shen G, Pan L, Liu W, Liang R, Lan T, Yang Y, Yang J, Liao J, Liu N. Ma H, et al. Among authors: liu n, liu w. Bioorg Med Chem. 2022 Feb 1;55:116600. doi: 10.1016/j.bmc.2021.116600. Epub 2022 Jan 5. Bioorg Med Chem. 2022. PMID: 34999526

7

In Vitro Anticancer Ability of Nano Fluorescent ¹¹¹ In-MIL-68/PEG-FA on Hela Cells.

Liang R, Liao Z, Li F, Ma H, Liu W, Chen X, Lan T, Yang Y, Liao J, Yang J, Liu N. Liang R, et al. Among authors: liu n, liu w. Chemistry. 2022 Apr 1;28(19):e202104589. doi: 10.1002/chem.202104589. Epub 2022 Mar 8. Chemistry. 2022. PMID: 35174917

8

PET imaging of VEGFR and integrins in glioma tumor xenografts using ⁸⁹Zr labelled heterodimeric peptide.

Liu W, Ma H, Li F, Cai H, Liang R, Chen X, Lan T, Yang J, Liao J, Yang Y, Liu N. Liu W, et al. Among authors: liu n. Bioorg Med Chem. 2022 Apr 1;59:116677. doi: 10.1016/j.bmc.2022.116677. Epub 2022 Feb 22. Bioorg Med Chem. 2022. PMID: 35220162

9

Targeted Alpha Therapy of Glioma Using ²¹¹At-Labeled Heterodimeric Peptide Targeting Both VEGFR and Integrins.

Liu W, Ma H, Liang R, Chen X, Li H, Lan T, Yang J, Liao J, Qin Z, Yang Y, Liu N, Li F. Liu W, et al. Among authors: liu n. Mol Pharm. 2022 Sep 5;19(9):3206-3216. doi: 10.1021/acs.molpharmaceut.2c00349. Epub 2022 Aug 22. Mol Pharm. 2022. PMID: 35993583

10

Alpha radionuclide-chelated radioimmunotherapy promoters enable local radiotherapy/chemodynamic therapy to discourage cancer progression.

Zhang J, Li F, Yin Y, Liu N, Zhu M, Zhang H, Liu W, Yang M, Qin S, Fan X, Yang Y, Zhang K, Yu F. Zhang J, et al. Among authors: liu n, liu w. Biomater Res. 2022 Sep 8;26(1):44. doi: 10.1186/s40824-022-00290-6. Biomater Res. 2022. PMID: 36076298 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59,871 results

Search Page

Filters